The COMPASS-CAT risk assessment model for predicting in-hospital venous thromboembolism in patients with breast, lung, colorectal, and ovarian cancer: A retrospective cohort study
Journal of International Medical Research · 2026-08 · 54 (8)
DOI: 10.1177/03000605261471674 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of International Medical Research, online erschienen am 13.08.2026. Verfasst von Hualin Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Hebei General Hospital, China. Hauptthemen laut MEDLINE: Venous Thromboembolism, Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Medical Science Research Project of Hebei.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Objective
To assess the predictive accuracy of the comparison of methods for thromboembolic risk assessment with clinical perceptions and awareness in real-life patients with cancer-associated thrombosis (COMPASS-CAT) risk model against the established Khorana score for predicting in-hospital venous thromboembolism in patients with solid tumors.
Methods
This retrospective cohort study analyzed 482 inpatients with breast, lung, colorectal, or ovarian cancer. Venous thromboembolism risk was stratified using the COMPASS-CAT and Khorana scores. The primary outcome was objectively verified in-hospital venous thromboembolism. Discriminative performance was evaluated using receiver operating characteristic curve analysis.
Results
Of the 482 patients, 53 (11.0%) developed in-hospital venous thromboembolism. The COMPASS-CAT model (score ≥7) demonstrated higher specificity (98.13% vs. 81.77%) and positive predictive value (82.22% vs. 35.00%) compared with the Khorana score (score ≥2). The COMPASS-CAT model exhibited significantly better overall discrimination, with an area under the curve of 0.913 versus 0.695 for the Khorana score (p < 0.001). Univariate logistic regression revealed that a COMPASS-CAT score ≥7 was strongly associated with elevated venous thromboembolism risk (odds ratio = 20.66, 95% confidence interval: 9.96–42.83). A Khorana score ≥2 was also associated with an increased risk, but the magnitude was weaker (odds ratio = 3.26).
Conclusion
The COMPASS-CAT model exhibited a promising discriminative trend over the Khorana score for identifying the risk of in-hospital venous thromboembolism. Its notably higher specificity and positive predictive value suggest that it may serve as a helpful supplementary tool for targeted thromboprophylaxis in the inpatient oncology setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Hebei General Hospital, China.
ORCID-Profile: Hualin Wei, Wei Han, Xianbo Zhang, Jing Zhao
Förderung
- the Medical Science Research Project of Hebei
Zitieren
APA
Wei, H., Han, W., Zhang, X., & Zhao, J. (2026). The COMPASS-CAT risk assessment model for predicting in-hospital venous thromboembolism in patients with breast, lung, colorectal, and ovarian cancer: A retrospective cohort study. Journal of International Medical Research, 54(8). https://doi.org/10.1177/03000605261471674
Vancouver
Wei H, Han W, Zhang X, Zhao J. The COMPASS-CAT risk assessment model for predicting in-hospital venous thromboembolism in patients with breast, lung, colorectal, and ovarian cancer: A retrospective cohort study. Journal of International Medical Research. 2026;54(8). doi:10.1177/03000605261471674
BibTeX
@article{Wei2026,
author = {Wei, Hualin and Han, Wei and Zhang, Xianbo and Zhao, Jing},
title = {The COMPASS-CAT risk assessment model for predicting in-hospital venous thromboembolism in patients with breast, lung, colorectal, and ovarian cancer: A retrospective cohort study},
journal = {Journal of International Medical Research},
year = {2026},
volume = {54},
number = {8},
doi = {10.1177/03000605261471674}
}
EUVIMED